Affordable Access

deepdyve-link
Publisher Website

First nation-wide study of diabetic retinopathy in Poland in the years 2013-2017.

Authors
  • Kozioł, Milena1, 2
  • Nowak, Michał S3, 4
  • Udziela, Monika2
  • Piątkiewicz, Paweł5
  • Grabska-Liberek, Iwona6
  • Szaflik, Jacek P2
  • 1 Department of Analyses and Strategies, Ministry of Health, 15 Miodowa str., 00-952, Warsaw, Poland. , (Poland)
  • 2 Department of Ophthalmology, Medical University of Warsaw, Public Ophthalmic Clinical Hospital (SPKSO), 13 Sierakowskiego str., 03-709, Warsaw, Poland. , (Poland)
  • 3 Provisus Eye Clinic, 112 Redzinska str., 42-209, Czestochowa, Poland. [email protected] , (Poland)
  • 4 Saint Family Hospital Medical Center, 19 Wigury str., 90-302, Lodz, Poland. [email protected] , (Poland)
  • 5 Department of Internal Diseases, Diabetology and Endocrinology, Medical University of Warsaw, 8 Kondratowicza str., 03-242, Warsaw, Poland. , (Poland)
  • 6 Department of Ophthalmology, Centre of Postgraduate Medical Education, 231 Czerniakowska str., 01-416, Warsaw, Poland. , (Poland)
Type
Published Article
Journal
Acta diabetologica
Publication Date
Oct 01, 2020
Volume
57
Issue
10
Pages
1255–1264
Identifiers
DOI: 10.1007/s00592-020-01540-6
PMID: 32500357
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

To assess the prevalence and time trends of diabetic retinopathy (DR) in the overall population of Poland from 2013 to 2017 and diagnose the risk factors of occurring DR among patients with diabetes mellitus (DM). Data from all levels of healthcare services at public and private institutions recorded in the National Health Fund (NHF) database were evaluated. International Classification of Diseases codes (ICD-9 and ICD-10) and unique NHF codes were used to identify DM type 1 and type 2 patients, DR and treatment procedures including laser photocoagulation, pars plana vitrectomy (PPV), anti-VEGF and steroid intravitreal injections. The overall registered prevalence of DR in the entire population of Poland was 0.81%. The mean prevalence of DR was 20.01% in the population with type 1 DM and 9.70% in the population with type 2 DM. In the study period, women represented 56.36% of all individuals registered with DR and 55.09% of all DM patients. In Poland, only 6.34% of all DM patients with DR received specific treatment with laser photocoagulation of the retina (82.32%), PPV (11.56%), anti-VEGF or steroid injections (5.15% and 0.97%, respectively). Cox regression hazard analysis showed that the risk of DR was associated with DM treatment only by GPs, female sex, coexisting systemic diseases and urban residence in both type 1 and type 2 DM. A 5-year retrospective analysis reveals the mean prevalence of DR in the population with type 1 and type 2 DM in Poland was rather low.

Report this publication

Statistics

Seen <100 times